Smartwatch monitoring for atrial fibrillation after stroke-The Pulsewatch Study: Protocol for a multiphase randomized controlled trial.

ABSTRACT:

Background

Atrial fibrillation (AF) is a common heart rhythm disorder that elevates stroke risk. Stroke survivors undergo routine heart rhythm monitoring for AF. Smartwatches are capable of AF detection and potentially can replace traditional cardiac monitoring in stroke patients.

Objective

The goal of Pulsewatch is to assess the accuracy, usability, and adherence of a smartwatch-based AF detection system in stroke patients.

Methods

The study will consist of two parts. Part I will have 6 focus groups with stroke patients, caretakers, and physicians, and a Hack-a-thon, to inform development of the Pulsewatch system. Part II is a randomized clinical trial with 2 phases designed to assess the accuracy and usability in the first phase (14 days) and adherence in the second

SUBMITTER: Dickson EL 

PROVIDER: S-EPMC8890084 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature